Resorcylic acid lactones (RAL) and dihydroxyphenylacetic acid lactones (DAL) represent important pharmacophores with heat shock response and immune system modulatory activities. The biosynthesis of these fungal polyketides involves a pair of collaborating iterative polyketide synthases (iPKSs): a highly reducing iPKS (hrPKS) whose product is further elaborated by a nonreducing iPKS (nrPKS) to yield a 1,3-benzenediol moiety bridged by a macrolactone. Biosynthesis of unreduced polyketides requires the sequestration and programmed cyclization of highly reactive poly-β-ketoacyl intermediates to channel these uncommitted, pluripotent substrates towards defined subsets of the polyketide structural space. Catalyzed by product template (PT) domains of the fungal nrPKSs and discrete aromatase/cyclase enzymes in bacteria, regiospecific first-ring aldol cyclizations result in characteristically different polyketide folding modes. However, a few fungal polyketides, including the DAL dehydrocurvularin, derive from a folding event that is analogous to the bacterial folding mode. The structural basis of such a drastic difference in the way a PT domain acts has not been investigated until now. We report here that the fungal versus the bacterial folding mode difference is portable upon creating hybrid enzymes, and structurally characterize the resulting unnatural products. Using structure-guided active site engineering, we unravel structural contributions to regiospecific aldol condensations, and show that reshaping the cyclization chamber of a PT domain by only three selected point mutations is sufficient to reprogram the dehydrocurvularin nrPKS to produce polyketides with a fungal fold. Such rational control of first ring cyclizations will facilitate efforts towards the engineered biosynthesis of novel chemical diversity from natural unreduced polyketides.
Introduction
Fungal polyketides are one of the largest families of structurally diverse natural products with antibiotic, antiproliferative, immunosuppressive, and enzyme inhibitory activities. Importantly, they also provide lead compounds and inspiration for pharmaceutical drug discovery, as evidenced by the statin cholesterollowering agents (1, 2) . Fungal polyketides are biosynthesized by multi-domain megasynthases (Type I iterative polyketide synthases, iPKSs) that employ ketoacyl synthase (KS), acyl transferase (AT), and acyl carrier protein (ACP) domains to catalyze recursive thio-Claisen condensations using malonyl-CoA extender units. While the architecture of these enzymes is similar to a single module of the bacterial Type I modular PKSs (3), fungal iPKSs use a single set of active sites iteratively, analogous to dissociated bacterial type II PKSs (4) . Fungal iPKSs may be classified into three subgroups (5) . Highly reducing iPKSs (hrPKSs) generate complex linear or non-aromatic cyclic products by reducing the nascent β-ketoacyl intermediates to the β-alcohol, the alkene, or the alkane after each condensation step, using their ketoreductase (KR), dehydratase (DH), and enoyl reductase (ER) domains to execute a cryptic biosynthetic program (2, (6) (7) (8) . Partially reducing iPKSs omit enoyl reduction to generate simple cyclic structures (5) . Finally, nonreducing iPKSs (nrPKSs) feature no reducing domains, and generate a wide variety of aromatic products. nrPKSs select different starter units by a starter unit:ACP transacylase (SAT) domain (9) , and mold the polyketide chains into cyclic products by regiospecific cyclizations. First-ring cyclizations are catalyzed by the product template domains (PT) (10) , while the polyketide chains are terminated by Claisen cyclase (11) , macrolactone synthase (12) (thioesterase, TE) or reductive release (R) domains (2) .
While the biosynthesis of most fungal polyketides requires a single iPKS enzyme, the assembly of the resorcylic acid lactones (RALs) involves a pair of collaborating hrPKS and nrPKS, acting in sequence (12) (13) (14) (15) (16) (17) . Fungal RALs are rich pharmacophores with estrogen agonist (zearalenone), mitogen-activated protein kinase inhibitory (hypothemycin), and heat shock response modulatory activities (radicicol and monocillin II (1), Fig. 1 ) (18, 19) . For these RALs, the hrPKS produces a reduced linear polyketide chain that is directly transferred to the nrPKS (9) . The nrPKS further extends the polyketide, closes the first 6-membered ring by aldol condensation, and releases the RAL product by macrolactone formation ( Fig. 1) . We have recently shown that the assembly of 10,11-dehydrocurvularin (2), a phytotoxic dihydroxyphenylacetic acid lactone (DAL) from Aspergillus terreus, employs a similar chemical modularity principle (20) . Curvularins modulate the mammalian immune system by repressing the inducible nitric oxide synthase (iNOS) (21, 22) . In addition, both monocillin II (1) and 10,11-dehydrocurvularin (2) act as promising broad spectrum inhibitors of various cancer cell lines in vitro by overwhelming the heat shock response, an evolutionarily conserved coping mechanism of eukaryotic cells that maintains protein homeostasis (23) (24) (25) (26) .
A crucial step during the programmed biosynthesis of aromatic polyketide natural products is the cyclization of the first ring, catalyzed by the PT domains of the nrPKS (10, 27) . This event commits the highly reactive, pluripotent poly-β-ketoacyl Submission PDF Fig. 1 . Biosynthesis of monocillin II (1) and 10,11-dehydrocurvularin (2) . (A) During the biosynthesis of the radicicol intermediate monocillin II (1) in Chaetomium chiversii (14) , the hrPKS CcRADS1 produces a reduced pentaketide starter unit (13) that is transferred to the nrPKS CcRADS2 by the SAT domain (9) (step 1). After a further four successive condensation events with malonyl-CoA (mCoA, step 2), catalyzed by the KS of the nrPKS CcRADS2, the linear ACP-bound polyketide chain undergoes a C2-C7 aldol condensation catalyzed by the PT domain (10) (step 3). This condensation follows an F-type folding mode (28, 29) . 1 is released by macrolactone formation catalyzed by the TE domain (2) (step 4). (B) Assembly of 2 in Aspergillus terreus AH-02-30-F7 also involves sequentially acting collaborating iPKSs. However, the hrPKS AtCURS1 produces a reduced tetraketide starter, while the AtCURS2 PT domain catalyzes aldol condensation in the C8-C3 register, following an S-type folding mode (28) . C-C bonds in bold indicate intact acetate equivalents (malonate-derived C 2 units) incorporated into the polyketide chain by the iPKSs. chains towards defined structural classes of the possible polyketide scaffold space. PT-catalyzed cyclizations most often follow an F-type pattern whereby the benzene ring is assembled from two intact malonate-derived C 2 units and from two bridging carbons from two additional acetate equivalents (28, 29) ( Fig. 1) . F-type first ring cyclizations typically result from aldol condensations in the C2-C7 (as in 1), C4-C9 or C6-C11 register. In contrast, bacterial polyketide cyclase/aromatase enzymes (parts of Type II PKS multienzyme complexes) typically direct an S-type folding event whereby the carbons of the benzene ring are derived from three intact malonate-derived C 2 units (1, 28) . Nevertheless, a select few fungal polyketides, including DALs like 2 feature a first ring connectivity that is analogous to the S-type folding mode, resulting from an unorthodox C8-C3 aldol cyclization event (20) . The bacterial aromatase/cylcase enzymes show little sequence similarity to fungal PT domains, and feature a different protein fold and active site architecture as a prominent example of convergent evolution (10, (30) (31) (32) . The sequences of fungal PT domains catalyzing F-type cyclization can be classified into seven clades according to their regiospecificity and the length of their product (29, 33) . In spite of catalyzing an atypical S-type folding, 137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202  203  204   2 www.pnas.org ------Footline Author   205  206  207  208  209  210  211  212  213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272 Submission PDF
Fig. 4.
Homology models of PT CcRADS2 and PT AtCURS2 .Cartoon views of the homology models, and stick representation of the amino acids lining the cyclization chambers of (A, C) PT AtCURS2 and (B, D) PT CcRADS2 . The side chains of residues discussed in the text are shown as golden sticks (catalytic histidine), magenta sticks (residues implicated in differentiating substrate orientation), and blue sticks (other significant residues). Green sticks: The substrate analog palmitic acid resident in the PT NSAS structure 3HRQ (10). the PT domain of the AtCURS2 curvularin synthase nrPKS is firmly rooted in the C2-C7 clade of PTs which yield RALs like 1 (20) . This result concurs with previous observations that fungal iPKS evolve orthogonal product specificities primarily by point mutations, and not by domain shuffling amongst distinct enzymes (2) .
The present work aimed to define how different regiospecific outcomes for first ring cyclization are programmed into nrPKS enzymes. By exploiting the orthogonal aldol condensation regiospecificities of the related PT domains of the nrPKSs for 1 and 2, we attempted to alter this program to switch F and S type cyclization modes. Achieving precise control of regiospecificity during the engineered biosynthesis of fungal polyketides is central to producing biologically active "unnatural products", and may guide efforts to generate novel chemical diversity from natural non-reduced fungal polyketides.
Results and Discussion
PT domains are necessary for programmed polyketide formation. Throughout this study, we have used an in vivo reconstituted system for polyketide production, whereby recombinant hrPKS + nrPKS pairs are expressed from compatible plasmids in the host Saccharomyces cerevisiae BJ5464-NpgA to produce 1 (9 mg/l, isolated yield), 2 (6 mg/l), and their derivatives (13, 34) . Deletion of PT domains has previously been shown in the Tang and Townsend laboratories to yield shunt metabolites whose backbones have undergone spontaneous cyclizations (12, 27, 29) . Thus, at the start of this work we considered it to be possible that PT AtCURS2 is simply an inactive enzyme that does not contribute to the folding of the nascent polyketide chain, and thus the DAL scaffold of 2 is a serendipitous derailment product retained by evolution. To exclude this possibility, we have deleted the PT domain of AtCURS2 as well as the PT domain of CcRADS2, the radicicol/monocillin II nrPKS of Chaetomium chiversii (14) . However, the corresponding yeast expression strains produced no polyketides (Fig. 2) . Complementation of the PT-less nrPKSs with their dissected PT domains, expressed as separate ORFs in trans, led to the rescue of the production of the native products 1 (1 mg/l) and 2 (2 mg/l), respectively (Fig. 2) . The success   273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340 Footline Author PNAS Issue Date Volume Issue Number  3   341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373  374  375  376  377  378  379  380  381  382  383  384  385  386  387  388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408 Submission PDF of this experiment contrasts previous in trans domain complementation attempts that did not yield observable products in vivo (1, 29) , and emphasizes that appropriate protein-protein docking, substrate recognition and processing still can take place with dissected domains expressed in heterologous hosts. Taken together, these experiments show that the PT-less nrPKSs and the freestanding PT domains are all catalytically active. The absence of RAL/DAL product formation in the absence of PT domains thus indicates that these domains fulfill an essential role in both systems, and that un-templated poly-β-ketones are not released by these nrPKSs. Portability of aldol cyclization programs. Recent experiments to replace PT domains in nrPKS model systems showed that the register of F-type aldol condensations may be switched (29, 35) , with the incoming PTs enforcing a subtle shift of the substrate chains in the catalytic chambers to expose different carbons (C2, C4 or C6) to the catalytic histidine for deprotonation and enolate formation (10) . Thus, we were interested to see whether first ring cyclizations may also be reconfigured between F-and S-type folding modes by exchanging PT domains. This would require radical re-routing of the polyketide substrate chain to expose a carbon to the catalytic base that is distal (S-type) or proximal (Ftype) to the phosphopantetheine thioester. As shown above and observed previously by others (1, 29, 36) , in trans reconstitution of iPKSs from dissected domains incurs a penalty for catalysis, in terms of product yield and/or fidelity. Thus, we elected to conduct these experiments with nrPKSs where the heterologous PT domains replace their native equivalents in cis (29) . Replacement of the PT domain of AtCURS2 with PT CcRADS2 led to the production of two isocoumarins, both resulting from C2-C7 aldol cyclizations. The priming acyl chain of 3 (0.3 mg/l) corresponds to the expected product of the hrPKS AtCURS1, while the major product 4 (3 mg/l) features a carbonyl at C15 ( Fig. 2A) . The formation of 3 and 4 indicates that PT CcRADS2 is able to process a shorter substrate (an octaketide as opposed to its native nonaketide) while faithfully executing an F-type first ring closure. Time course analysis of the fermentation with S. cerevisiae BJ5464-NpgA [YEpAtCURS1 and YEpATCURS2-PT CcRADS2 ] (Fig. 3A) shows that 3 is the primary product 24 hr after the induction of polyketide production, but by 48 hr the formerly minor product 4 becomes dominant. Extending the cultivation to 72 hr and beyond increased only the production of 4 but did not eliminate 3, nor did it lead to the production of additional polyketide products. Similarly, incubation of purified 3 with the untransformed yeast host strain S. cerevisiae BJ5464-NpgA led to the gradual, albeit not complete, biotransformation of 3 to 4 (Fig. 3B ). It was confirmed that the untransformed yeast host strain does not produce 3 or 4, nor is 3 converted to 4 by spontaneous oxidation in the culture medium in the absence of yeast cells (Fig. 3B) . Thus, 4 derives from a chance oxidation of the 15-OH of 3 by an endogenous enzyme of the yeast host.
The yeast strain co-expressing CcRADS1 and CcRADS2-PT AtCURS2 yielded a novel compound (5, Fig. 2B) , although with a low productivity (0.3 mg/l). Structural characterization of this product revealed that 5 harbors a novel carbon skeleton featuring a C8-C3 dihydroxyphenylacetic acid moiety bridged by an 8membered lactone (SI Methods). Thus, PT AtCURS2 is competent to process a longer substrate (a nonaketide as opposed to its native octaketide) while retaining its ability to direct an S-type folding and cyclization event. The 4-oxo-2-oxacyclooctanone ring of 5 may be produced by the facile attack of the C1 carboxyl on C11 of the enone; the involvement of the TE domain in this reaction cannot be excluded at this point.
Collectively, these experiments show that the F-or S-type regiospecificities of first ring cyclizations are solely programmed into the PT domains of collaborating nrPKSs (29, 35) . This programming is portable amongst nrPKS platforms, without influ-encing starter unit choice or the number of extensions carried out by the rest of the chassis. The formation of the isocoumarins 3 and 4 and the 8-membered lactone 5 suggests that the nrPKS TE domains may hydrolyze products with switched aldol condensation patterns, but they are unable to form a macrolactone using a carbon chain with an isomeric fold. The low product yield of 5 suggests that CcRADS2 is a more stringent chassis, less amenable to combinatorial replacement of its domains.
Homology models of PT AtCURS2 and PT CcRADS2 . To identify the structural basis of the programming of regiospecificity in PT domains, we have created homology models of the PT AtCURS2 and the PT CcRADS2 domains, based on the experimentally determined structure of the PT domain of NSAS from Aspergillus parasiticus (PT NSAS , PDB ID: 3HRR and 3HRQ) (10) . The nrPKS NSAS catalyzes the formation of norsorolinic acid, a C 20 polyketide primed with hexanoic acid, with the PT NSAS directing an F-type folding mode first ring cyclization event (28) in the C4-C9 register, followed by a second ring closure at C2-C11.
In spite of relatively low sequence similarities with PT NSAS (PT AtCURS2 : 22% identity and 41% similarity; PT CcRADS2 : 20% identity and 40% similarity), combined structural evaluation and fold recognition scores of 3.6 (PT CcRADS2 ) and 3.47 (PT AtCURS2 ) obtained from the reliability assessment engine PCONS5 (37) indicated that the fold recognition is reliable for both PT AtCURS2 and PT CcRADS2 (a PCONS score > 2.17 is considered reliable, a score > 1.5 is considered significant). PT NSAS features a long, straight cyclization chamber and a hydrophobic hexyl-binging region that accommodates the starter unit, with the substrate bound in an extended conformation (10) . In contrast, homology modeling had suggested that PKS4, the zearalenone nrPKS from Gibberella fujikuroi (10, 16, 38) contains a PT domain with a wider, curved catalytic chamber where the substrate adopts a bent conformation (10) . Similar to the model proposed for PT PKS4 , the hydrophobic hexyl-binding region present in PT NSAS was found to be closed off in both PT AtCURS2 and PT CcRADS2 by the bulky side chains of two phenylalanine residues (Fig. 4) . First, a replacement of M 1495 of NSAS by phenylalanine (AtCURS2: F 1449 , CcRADS2: F 1472 ) narrows the hexyl-binding region. Next, the side chain of another phenylalanine residue in place of G 1491 (AtCURS2: F 1445 , CcRADS2: F 1468 ) directly clashes with the tail of the palmitic acid that occupies this pocket in structure 3HRR. This latter phenylalanine is also conserved not only in all other RAL PT domains (14) (15) (16) 38) , but also in clades II, III and V of characterized PT domains (29) . Thus, the hrPKS-derived reduced acyl chains of the nascent intermediates for 1 and 2 may not be sequestered in a deep, buried pocket (10) in these enzymes.
The RAL/DAL PT models retain the large substrate binding chamber where cyclization occurs (10) . This cyclization chamber appears constricted at the residues corresponding to V 1347 and A 1397 of NSAS (AtCURS2: M 1310 and P 1356 , CcRADS2: M 1327 and P 1374 ) but this is compensated by substitutions with less bulky side chains corresponding to P 1355 and W 1571 (AtCURS2: G 1318 and F 1524 , CcRADS2: G 1335 and F 1550 , Fig. 4) . The cyclization chamber is proposed to feature an active site dyad (AtCURS2: H 1308 , E 1497 ; CcRADS2: H 1325 , E 1520 ) where the aspartic acid (D 1543 ) that polarizes the catalytic base (H 1345 ) in NSAS is replaced by glutamic acid. This functionally conserved replacement is present in all known RAL and DAL PT domains (14) (15) (16) 38) , but not in clades II-V of functionally characterized PT domains (29) . The same D to E replacement is nonetheless common in dehydratases with a fold similar to those of PT domains, and was also found in some Type II PKS aromatase/cyclase enzymes (32) . After deprotonation of C8 (AtCURS2) or C2 (CcRADS2) by the catalytic base, the enolate intermediate is thought to be stabilized by the backbone amine of V 1521 (AtCURS2) or N 1547 (CcRADS2) (10) . After the collapse of the enolate and aldol addition to the Submission PDF carbonyl, the oxyanion may be stabilized by a network of water molecules that are coordinated in NSAS by S 1356 , D 1543 , T 1546 and N 1568 . Only some of these residues are conserved in AtCURS2 (S 1319 , E 1497 , V 1500 , and V 1521 ) and CcRADS2 (S 1336 , E 1520 , V 1523 , and N 1547 ), and similar replacements are also present in all RAL PT domains (14) (15) (16) 38) . The second half of the oxyanion hole is provided by the backbone amine of a glycine in DH domains and hydratases with which PT domains share a double hot dog fold and a proposed evolutionary origin (10) . For NSAS, this glycine was seen to be replaced by P 1355 , but this residue is restored to glycine in all known RAL PT domains (14-16, 38) (AtCURS2: G 1318 ; CcRADS2: G 1335 ). The corresponding position is occupied by serine in clades II, III and V of PT domains (29) . The electrophilic carbonyl that takes part in the aldol cyclization is polarized via hydrogen bonding through the same water network, while hydrogen bonding with an asparagine that is conserved in all functionally characterized PT domains (29) may help to orient the substrate in the chamber (NSAS: N 1554 ; AtCURS2: N 1508 , CcRADS2: N 1531 ).
Conversion of S-and F-type folding modes by structurebased site-directed mutagenesis. A superimposition of the models for PT AtCURS2 and PT CcRADS2 (47% sequence identity and 65% similarity) showed that the active sites and the cyclization chambers of these two enzymes are highly conserved. Nevertheless, PT AtCURS2 forms a first ring in the C8-C3 register with a folding mode analogous to the S-type, while PT CcRADS2 catalyzes an Ftype folding mode (28) first ring closure in the C2-C7 register. We have identified three key differences that we hypothesized would result in a change in substrate orientation in the binding pocket, and lead to the orthogonal cyclization regiospecificities observed in 1 vs. 2 (Fig. 5A) . First, L 1609 of PT CcRADS2 is replaced by W 1584 near the substrate entrance in PT AtCURS2 . The bulky side chain of this tryptophan narrows the entrance of the cyclization chamber of PT AtCURS2 , and may serve to direct C2 of the penetrating acyl chain away from the catalytic histidine. Leucine is strictly conserved at this position in all characterized RAL PTs (14) (15) (16) 38) and predominates (with methionine as an alternative) in clade II-V PTs catalyzing various F-type cyclizations (29) . Next, both PT AtCURS2 and PT CcRADS2 (as well as all other characterized RAL PTs (29)) display a tyrosine-phenylalanine residue pair on opposing faces at the rear of the binding pocket. Remarkably, these residues are inverted in PT AtCURS2 vs. all known RAL PT domains (PT AtCURS2 : F 1455 and Y 1576 , PT CcRADS2 : Y 1478 and F 1601 ). By participating in hydrogen bond networks (Y) or by contributing to a hydrophobic surface of the pocket (F), these residues may help to position the chain such that either C8 (PT AtCURS2 ) or C2 (PT CcRADS2 ) would be presented to the catalytic base (PT AtCURS2 : H 1308 , PT CcRADS2 : H 1325 ), leading to S-type (PT AtCURS2 ) or F-type (PT CcRADS2 ) cyclization outcomes. Notably, all three distinguishing residues (W 1584 , F 1455 and Y 1576 ) are conserved between PT AtCURS2 and the PT domain of an orphan hrPKS-nrPKS system in the genome of Pyrenophora triticirepentis PT-1C-BFP (GenBank: EDU47225 and EDU47223): this putative DAL synthase is the closest ortholog of the dehydrocurvularin synthase AtCURS1-AtCURS2 (20) . Although the highlighted residues are positioned such that substrate binding is expected to be affected, verification of the specific contacts must await the determination of the crystal structures of these domains with bound substrates/products. In the meantime, these three residues may serve as distinguishing sequence signatures to predict RAL vs. DAL formation by orphan biosynthetic systems found in sequenced fungal genomes.
To test our structural analysis, we systematically replaced one, two or all three of the identified residues (F 1455 , Y 1576 , and W 1584 ) in AtCURS2 with their counterparts of CcRADS2, and co-expressed these enzymes with AtCURS1 in yeast. Single mutations did not alter the regiospecificity of first ring closure in the product (Fig. 5B) . Double mutations either eliminated product formation (F 1455 Y + W 1584 L), or yielded a mixture of 2 and 4, indicating a relaxed aldol condensation regiospecificity for some of these mutant enzymes. Finally, the enzyme with all three mutations produced only 3 and 4 (0.2 and 2 mg/l, respectively), with no detectable 2. Thus, these three selected point mutations were sufficient to completely transform the native C8-C3 (S-type) regiospecificity of PT AtCURS2 to C2-C7 (F-type, Fig. 5B ). The converse experiment (replacing Y 1478 , F 1601 and L 1609 in CcRADS2 with the corresponding residues of AtCURS2 in all combinations) reduced the yield or completely eliminated the production of 1, but did not provide 5 or any other detectable C8-C3 DAL (Fig. S1) . The absence of the expected product may not be surprising if we consider the low yield of 5 even with CcRADS2-PT AtCURS2 , where the incoming PT AtCURS2 domain has presumably been optimized by evolution for the effective synthesis of C8-C3 products. A similar recalcitrance to alteration of stereocontrol has been noted for KR and ER domains during site-directed mutagenesis (but not during complete domain exchanges) in the context of modular PKS systems. Presumably, any proofreading activity from downstream domains (e.g. the TE in our system) may override the effects of subtle alterations of the active site architecture (3, 39, 40) .
The current work affirms that first ring cyclization regiospecificity in fungal collaborating iPKSs is programmed in the composition and geometry of the cyclization chambers of the PT domains. Exploiting structural information on PT domains, we have gained insight into the origins of the programming of this folding specificity. Replacement of just three select residues of the product cyclization chambers in a keyhole surgery-like approach converted a PT domain from an atypical, C8-C3-specific, S-type folding mode cyclase into a typical, C2-C7-selective, F type folding mode enzyme, as predicted. The identified signature residues may be used to predict polyketide folding modes in orphan RAL/DAL biosynthetic systems. More importantly, rational reprogramming of polyketide folding modes in fungal iPKSs opens new possibilities for the engineered biosynthesis of novel unnatural polyketides with isomeric folds, including cancer cell proliferation inhibitors and immune system modulators.
Materials and Methods
Strains and Culture Conditions. E. coli DH10B and plasmid pJET1.2 (Fermentas) were used for routine cloning and sequencing. Saccharomyces cerevisiae BJ5464-NpgA (MATα ura3-52 his3-Δ200 leu2-Δ1 trp1 pep4::HIS3 prb1 Δ1.6R can1 GAL) (34, 41) was maintained on yeast extract peptone dextrose agar (YPD, Difco), and transformed using the small scale lithium chloride protocol (42) . The yeast -E. coli shuttle vectors YEpADH2p-FLAG-URA and YEpADH2p-FLAG-TRP (20) are based on the YEpADH2p vectors with the URA3 or with the TRP1 selectable markers (13) . Primers used in this study are listed in Table  S2 . Details on the construction of gene variants and expression constructs are described in the SI Methods. For each recombinant yeast strain, three to five independent transformants were analyzed for the production of polyketides by small scale fermentation, and fermentations with representative isolates were repeated at least three times to confirm results.
Small scale fermentation and analysis of products. Yeast strains were cultured in 50 mL of SC medium (0.67% yeast nitrogen base, 2% glucose, and 0.72 g/L Trp/Ura DropOut supplement) at 30°C with shaking at 250 rpm. When the OD 600 reached 0.6, an equal volume of YP medium (1% yeast extract, 2% peptone) was added to the cultures, and the fermentation was continued at 30°C with shaking at 250 rpm for an additional 2 days. The cultures were adjusted to pH 5.0, and extracted with equal volumes of ethyl acetate three times. The collected organic extracts were evaporated to dryness and analyzed by reversed phase HPLC (Kromasil C18 column, 5 µm, 4.6 mm × 250 mm; eluted with 5% aqueous acetonitrile for 5 min, followed by a linear gradient of 5-95% CH 3 CN over 10 min, and 95% CH 3 CN for 10 min at a flow rate of 0.8 mL/min; detection at 300 nm). Analysis of the time course of the production of 3 and 4, biotransformation of 3 to 4 by Saccharomyces cerevisiae BJ5464-NpgA, and scale-up of fermentations and isolation of polyketide products for structure elucidation are described in the SI Methods .   545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594 
